Holen Sie sich die Stockscreener-App
0.6571
3.14%
0.02
Vorhandelsmarkt:
.62
-0.0371
-5.65%
Femasys Inc Aktie (FEMY) Neueste Nachrichten
Femasys surges on Fembloc FDA approval, $58 million funding news | Tap to know more | Inshorts - Inshorts
Can Femasys Inc. stock reach $100 price target2025 Price Targets & Advanced Swing Trade Entry Alerts - newser.com
Is Femasys Inc. stock affected by interest rate hikesJuly 2025 Closing Moves & Proven Capital Preservation Tips - newser.com
Femasys Stock Sparks Retail Frenzy After FDA Clears Final Phase Of FemBloc Trial And $58M Financing - Stocktwits
Femasys Secures Fda Approval to Advance Final Fembloc Trial Phase and $12 Million Financing, with Potential to Reach $58 Million - MarketScreener
Femasys Inc. announced that it expects to receive $12 million in funding - MarketScreener
Will Femasys Inc. stock benefit from commodity pricesSwing Trade & Free Reliable Trade Execution Plans - newser.com
Femasys gets FDA OK for final FemBloc trial, secures $12M financing, stock surges - MSN
Femasys Receives FDA Approval for FemBloc Trial - TipRanks
Applying Elliott Wave Theory to Femasys Inc.Weekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com
Femasys Inc Secures FDA Approval for Final FemBloc Trial Phase - TradingView
FDA approves Femasys to continue pivotal trial for non-surgical birth control - Investing.com
Femasys secures FDA approval to advance final FemBloc trial phase - TipRanks
Femasys Inc. Advances FemBloc Toward FDA Approval with Successful Trial Completion and $12 Million Financing - Quiver Quantitative
Why Femasys Inc. stock is considered a top pickMarket Movement Recap & Expert Approved Momentum Ideas - newser.com
Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, ... - Caledonian Record
Femasys Secures FDA Approval to Advance Final FemBloc® - GlobeNewswire
Exit strategy if you’re trapped in Femasys Inc.2025 Breakouts & Breakdowns & Technical Pattern Based Signals - newser.com
Is Femasys Inc. stock a safe haven assetPortfolio Update Report & Long-Term Safe Investment Plans - newser.com
Is Femasys Inc. forming a bottoming base2025 Volatility Report & Long-Term Growth Stock Strategies - newser.com
Femasys Meets Nasdaq Equity Requirement After Offering - MSN
Custom watchlist performance reports with Femasys Inc.Earnings Overview Summary & Accurate Buy Signal Notifications - newser.com
Will Femasys Inc. stock continue upward momentum2025 Top Gainers & Daily Price Action Insights - newser.com
What margin trends mean for Femasys Inc. stockTrade Risk Report & Daily Profit Maximizing Tips - newser.com
What to do if you’re stuck in Femasys Inc.Quarterly Investment Review & Free Expert Approved Momentum Trade Ideas - newser.com
Is Femasys Inc. stock positioned well for digital economyPortfolio Update Summary & Consistent Profit Trading Strategies - newser.com
How institutional buying supports Femasys Inc. stockWeekly Stock Report & Risk Managed Investment Strategies - newser.com
Why Femasys Inc. stock is favored by pension fundsTrade Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
Combining machine learning predictions for Femasys Inc.Stock Surge & Weekly High Return Stock Opportunities - newser.com
Applying Wyckoff theory to Femasys Inc. stockEarnings Risk Report & High Return Stock Watch Alerts - newser.com
1.41%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):